{"brief_title": "Phase II Study of Novantrone(R) (Mitoxantrone) and Etoposide in Patients With HIV Associated Large Cell and Immunoblastic Lymphomas", "brief_summary": "To determine the efficacy and toxicity of the combination of mitoxantrone hydrochloride ( Novantrone ) and etoposide in the treatment of patients with HIV associated lymphomas.", "condition": ["Lymphoma, Non-Hodgkin", "HIV Infections"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Mitoxantrone hydrochloride", "Etoposide"], "criteria": "Inclusion Criteria Patients must have the following: - Positive HIV antibody, positive HIV culture or antigen capture, or prior diagnosis of AIDS by the CDC criteria. - Diagnosis by pathological examination of large cell or immunoblastic lymphoma within measurable or evaluable disease. - Pneumocystis carinii pneumonia (PCP) prophylaxis during the course of the study. - Signed written informed consent. Exclusion Criteria Co-existing Condition: Patients with the following conditions or symptoms are excluded: - Acute intercurrent opportunistic infection, such as Pneumocystis carinii pneumonia (PCP) diagnosed within 3 weeks. - Stage IE Central Nervous System lymphomas. Patients with the following are excluded: - More than one previous treatment for lymphoma. - Acute intercurrent opportunistic infection, such as Pneumocystis carinii pneumonia (PCP) diagnosed within 3 weeks. - Conditions that preclude obtaining an informed consent. - Not accessible for scheduled treatment visits or follow-up. - Stage IE Central Nervous System (CNS) lymphomas. Prior Medication: Excluded within 2 weeks of study entry: - Zidovudine. - Excluded: - Doxorubicin dosing = or > 300 mg/m2. Prior Treatment: Excluded: - Received more than one previous treatment regimen for lymphoma. Required: - Prophylactic treatment for Pneumocystis carinii pneumonia (PCP) prophylaxis.", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "keyword": "Acquired Immunodeficiency Syndrome", "mesh_term": ["Lymphoma", "HIV Infections", "Lymphoma, Non-Hodgkin", "Plasmablastic Lymphoma", "Lymphoma, Large-Cell, Immunoblastic", "Etoposide", "Mitoxantrone", "Etoposide phosphate"], "id": "NCT00002003"}